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Abstract: In our ongoing study to evaluate the antiprotozoal activity of alkamides from
Asteraceae, a dichloromethane extract from the roots of Anacyclus pyrethrum L. showed
a moderate in vitro activity against the NF54 strain of Plasmodium falciparum and against
Leishmania donovani (amastigotes, MHOM/ET/67/L82 strain). Seven pure alkamides and
a mixture of two further alkamides were isolated by column chromatography followed by
preparative high performance liquid chromatography. The alkamides were identified by mass- and
NMR-spectroscopic methods as tetradeca-2E,4E-dien-8,10-diynoic acid isobutylamide (anacycline, 1),
deca-2E,4E-dienoic acid isobutylamide (pellitorine, 2), deca-2E,4E,9-trienoic acid isobutylamide (3),
deca-2E,4E-dienoic acid 2-phenylethylamide (4), undeca-2E,4E-dien-8,10-diynoic acid isopentylamide (5),
tetradeca-2E,4E,12Z-trien-8,10-diynoic acid isobutylamide (6), and dodeca-2E,4E-dien acid
4-hydroxy-2-phenylethylamide (7). Two compounds—undeca-2E,4E-dien-8,10-diynoic acid
2-phenylethylamide (8) and deca-2E,4E-dienoic acid 4-hydroxy-2-phenylethylamide (9)—were
isolated as an inseparable mixture (1:4). Compounds 3, 4, and 5 were isolated from
Anacyclus pyrethrum L. for the first time. While compounds 4 and 5 were previously known
from the genus Achillea, compound 3 is a new natural product, to the best of our knowledge.
All isolated alkamides were tested in vitro for antiprotozoal activity against Plasmodium falciparum,
Trypanosoma brucei rhodesiense, Trypanosoma cruzi, and Leishmania donovani and for cytotoxicity against
L6 rat skeletal myoblasts.
Keywords: Anacyclus pyrethrum L.; antiprotozoal activity; alkamide; Plasmodium falciparum;
Trypanosoma brucei rhodesiense; Trypanosoma cruzi; Leishmania donovani
1. Introduction
Alkamides represent a class of natural products with considerable structural diversity and
a broad spectrum of bioactivities [1]. In a previous study, alkamides from Achillea ptarmica L.
(sneezewort yarrow, Asteraceae) showed activity against Plasmodium falciparum (Pf ) and Trypanosoma
brucei rhodesiense (Tbr), causative agents of tropical malaria (Pf ) and human African trypanosomiasis
(HAT, “Sleeping Sickness”; Tbr), respectively. However, the activity of the isolated alkamides could
not conclusively explain the high activity of the tested dichloromethane extract against T. b. rhodesiense
(IC50 0.67 µg/mL) [2]. Recently, an alkamide structurally related to those found in A. ptarmica but with
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an endoperoxide structure was isolated from Acmella ciliata, (also Asteraceae) and showed considerable
antiplasmodial activity against Pf [3].
These studies on alkamides from Asteraceae were extended to Anacyclus pyrethrum L. and its
alkamide constituents. From a phylogenic point of view, Anacyclus pyrethrum is closely related to
Achillea ptarmica L. within the tribe Anthemideae of Asteraceae [4–6], and both species are known
to contain a structural pattern similar to alkamides [7]. A. pyrethrum has been known since ancient
times for its use as medicinal plant used—among other ailments—against recurring fevers (De Materica
Medica [8]), and it was mentioned in a review by Adams as one of the plants used against malaria during
the Renaissance (16th and 17th century) [9]. In a bioactivity study associated with the mentioned review,
antiplasmodial activity was reported for an ethyl acetate extract of A. pyrethrum roots, but without
mentioning the level of activity in terms of an IC50 value and without specification of the active
constituents [10]. We recently reported on the antiprotozoal IC50 values of a dichloromethane extract
from this plant drug, including a value of 3 µg/mL for the activity against Plasmodium falciparum [2].
The aim of the present study was therefore to evaluate the antiprotozoal activity of the alkamides
in the roots of A. pyrethrum.
2. Results and Discussion
2.1. Isolation and Structural Characterization of the Alkamides
The major alkamides of A. pyrethrum roots were isolated from the dichloromethane extract by
column chromatography (CC) on silica with an n-hexane-ethylacetate gradient followed by preparative
high performance liquid chromatography (HPLC) of representative CC-fractions (XV, XIX, XX and
XXII) selected on the basis of their UHPLC/+ESI QqTOF MS chromatograms (see Figure 1).
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Figure 1. UHPLC/+ESI QqTOF MS-MS chromatograms of the CH2Cl2-extract of Anacyclus pyrethrum 
L. (A) c = 10 mg/mL and the selected fractions (B–E) c = 5 mg/mL. (B) fraction XV, (C) fraction XIX, 
(D) fraction XX, and (E) fraction XXII. All peaks are labelled with the measured m/z values and 
compound numbers. Blue represents base peak chromatogram m/z 100–500, and magenta represents 
base peak UV-chromatogram at 260 nm. 
The alkamides were identified by their exact molecular masses determined by UHPLC/+ESI-
QTOF-MS/MS and by NMR spectroscopy. 
The main component of fraction XIX (Figure 1, chromatogram C) with m/z 272.2020 [M + H]+ was 
identified by its mass and NMR data as tetradeca-2E,4E-dien-8,10-diynoic acid isobutylamide 
(anacycline, 1) in direct comparison with the compound previously isolated from A. ptarmica and 
literature data [2,11]. Three compounds were isolated from fraction XV (Figure 1, chromatogram B). 
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The main component of fraction XIX (Figure 1, chromatogram C) with m/z 272.2020 [M + H]+
was identified by its mass and NMR data as tetradeca-2E,4E-dien-8,10-diynoic acid isobutylamide
(anacycline, 1) in direct comparison with the compound previously isolated from A. ptarmica and
literature data [2,11]. Three compounds were isolated from fraction XV (Figure 1, chromatogram B).
Compound 2 (m/z 224.2027 [M + H]+) was identified (in the same manner as 1) as deca-2E,4E-dienoic
acid isobutylamide (pellitorine) [2,12]. Compound 3 (m/z 222.1873 [M + H]+) displayed a similar
1H-NMR spectrum as 2, but with signals typical of a pair of germinal olefinic protons at position C-10
(Figure S1). All proton resonances were assigned to the corresponding 13C-NMR signals (Figure S2)
by an HSQC experiment (Figures S3 and S4), and the 1H/1H COSY as well as 1H/13C HMBC spectra
(Figures S5–S7) allowed unambiguous assignment of structure of 3 as deca-2E,4E,9-trienoic acid
isobutylamide (9,10-dehydropellitorine; Figure 2)—a new natural product to the best of our knowledge.
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Fraction XX (Figure 1, chromatogram D) contained—besides further anacycline (1, m/z 272.2003 
[M + H]+)—two further compounds which could be identified as undeca-2E,4E-dien-8,10-diynoic acid 
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constant of H-12 and H-13 was 11 Hz. Since no NMR data proving the double bond geometry
were reported in the original literature [14], it cannot be excluded that the reported constituent of A.
pyrethrum was identical with compound 6. It could be possible, however, that both isomers occur in
the plant.
In fraction XXII (Figure 1, chromatogram E), three compounds (7–9) with [M + H]+ adduct
ions at m/z 316.2281, 278.1543 and 288.1982, respectively, were isolated, with the latter two
in a mixture of approximately 1:4. Their NMR spectra in comparison with literature [15]
allowed unambiguous identification as dodeca-2E,4E-dien acid 4-hydroxy-2-phenylethylamide (7),
undeca-2E,4E-dien-8,10-diynoic acid 2-phenethylamide (8), and deca-2E,4E-dienoic acid 4-hydroxy-2-
phenylethylamide (9), respectively, all known constituents of A. pyrethrum [15].
2.2. Antiprotozoal Activity of the Isolated Alkamides
The IC50 values for the in vitro antiprotozoal activity against Trypanosoma brucei rhodesiense
(Tbr), Trypanosoma cruzi (Tc), Leishmania donovani (Ld) and Plasmodium falciparum (Pf ), as well as the
cytotoxicity against L6 rat skeletal myoblasts of the crude dichloromethane extract from A. pyrethrum
roots and of anacycline and pellitorine (1 and 2) were tested earlier under identical conditions, and the
results were reported in our earlier study [2]. The respective data of the isolated compounds 3–7 as
well as the 1:4 mixture of 8 + 9 were determined in this study and are reported in Table 1.
Table 1. In vitro antiprotozoal and cytotoxic activity (IC50 values in µg/mL; values in µM of pure
compounds are reported in brackets) of the dichloromethane (DCM) extract from Anacyclus pyrethrum
roots and of the isolated alkamides (3–5). Selectivity indices (SIs) represent the ratio of cytotoxic over
antiprotozoal IC50 values. Data are means of two independent determinations ± deviation from mean
value. The in vitro activity data of 1 (anacycline) and 2 (pellitorine) was previously reported by us [2].
Sample Tbr 1 Tc 2 Ld 3 Pf 4 Cytotox 5
SI
Tbr
SI
Ld
SI
Pf
Pos. contr.
0.003 ± 0.001 0.439 ± 0.094 0.127 ± 0.052 0.080 ± 0.003 0.008 ± 0.001
(0.008) (1.688) (0.312) (0.250) (0.019)
DCM extr. 6 >10 8.83 ± 0.75 4.22 ± 1.57 3.04 ± 0.07 13.4 ± 3.2 >1.3 3.2 4.4
3
2.91 ± 0.21 39.9 4.77 ± 1.02 7.13 ± 0.63 16.7 ± 0.1
5.7 3.5 2.3(13.2) (181) (21.6) (32.2) (75.3)
4
4.03 5.02 ± 0.05 2.97 ± 0.54 >5 7.88
2.0 2.7 >1.6(14.9) (18.5) (11.0) (>18) (29.1)
5
4.59 ± 0.39 16.3 ± 0.3 4.04 ± 0.71 10.3 ± 1.4 28.2 ± 6.9
6.2 7.0 2.7(18.9) (66.9) (16.6) (42.5) (116)
6
6.37 ± 0.94 38.8 ± 2.1 5.04 ± 1.17 7.19 ± 0.49 19.4 ± 1.7
3.1 3.9 2.7(23.7) (144) (18.7) (26.7) (72.2)
7
2.26 ± 0.18 1.88 4.19 ± 1.64 3.18 ± 0.20 0.19 ± 0.05
0.1 <0.1 <0.1(7.17) (5.97) (13.3) (10.1) (0.69)
8 + 9 (1:4) 1.66 ± 0.12 3.90 5.31 ± 0.53 7.64 ± 2.57 2.47 ± 0.36 1.5 0.5 0.3
1 T. b. rhodesiense (STIB 900 strain, bloodstream trypomastigotes, positive control: melarsoprol); 2 T. cruzi (Tulahuen
C4 strain; intracellular amastigotes, pos. contr.: benznidazole); 3 L. donovani (MHOM-ET-67/L82 strain, axenic
amastigotes, pos. contr.: miltefosine); 4 P. falciparum (NF54 IEF, pos.: chloroquine); 5 Cytotoxicity (L6 rat skeletal
myoblast cell line, pos.contr.: podophyllotoxin); 6 Data for the crude extract were previously reported and are
repeated here for comparison [2].
On the background of the reported medicinal use as an antimalarial [8,9], it appears noteworthy
that the crude extract displayed its highest activity against Pf, even though the IC50 value of 3 µg/mL
is relatively moderate. The most active single constituent against this parasite is compound 7 with
an IC50 in the same range (3.2 µg/mL), and about equal to that of the pellitorine (2, 3.3 µg/mL) [2].
Compound 7 was also found to be the most active compound against Tc. Unfortunately, however,
the antiparasitic activity of 7 is not selective. The compound, as the only one in the series, displayed
considerable cytotoxicity with an IC50 of only 0.2 µg/mL, so further studies on its antiprotozoal activity
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do not appear to be useful. The mixture of 8 and 9 displayed some activity against Tbr, but with little
selectivity. The major component in this mixture (9) is structurally very similar to 7, and hence is likely
to dominate the observed antitrypanosomal as well as cytotoxic activity. The ratio of cytotoxic over
antitrypanosomal activity being more favorable for the 8 + 9 mixture than for 7, it could be expected
that 9 with its C10 acyl moiety, as a pure compound, would be more active and selective against
Tbr than its C12 homologue 7. In terms of structure–activity relationships, the p-hydroxy-substituted
phenethyl amide moiety of these two compounds appears to confer higher toxicity to trypanosomatid
as well as mammalian cells than the unsubstituted phenethyl amide moiety or the aliphatic amide
groups. The other compounds showed only moderate activity against all tested parasites, and also low
cytotoxicity. No clear-cut structure–activity relationships became evident for these compounds.
Taken together, the two alkamides 2 and 7 are likely to be responsible for the major part of the
antiplasmodial effect of the crude extract, and thus related to the ethnomedical use of A. pyrethrum as
an antimalarial. It must remain an open question at present whether this use was justified and whether,
possibly, other compounds from yet-untested fractions contribute to the overall effect.
3. Materials and Methods
3.1. Analytical Procedures and Instruments
3.1.1. UHPLC/+ESI-QTOF-MS/MS
The analytical profiling of samples were performed on the already-described system with the
identical method [2].
Sample concentration: concentration of pure compounds: 0.1 mg/mL (1–7) or 0.2 mg/mL (8 + 9)
in methanol; concentration of fractions: 5 mg/mL; concentration of crude extract: 1 or 10 mg/mL.
3.1.2. NMR Spectroscopy
Nuclear magnetic resonance spectra were recorded on an AS 400 Mercury plus spectrometer
(Varian, Palo Alto, CA, USA) at 400 (1H, 5 and 6), 600 (1H, 1–4 and 7–9) and 100 MHz (13C) CDCl3 at
room temperature. They were referenced to the solvent signals (δH 7.260 ppm, δC 77.000 ppm).
3.2. Isolation Process
3.2.1. Plant Material
The plant material (roots of Anacyclus pyrethrum L.; latin description: Pyrethi radix; specification:
“scharf” (= “spicy”), powdered) was purchased from Alfred Galke (Bad Grund, Germany). A voucher
specimen (# TS_Apy_01) is deposited at the IPBP herbarium.
3.2.2. Sohxlet Extraction
The powdered plant material (604 g) was exhaustively extracted in two equal portions with
dichloromethane (1500 mL each) in a Soxhlet apparatus for 11 h. The extract was evaporated to
dryness under reduced pressure, yielding 14 g of crude extract.
3.2.3. Gravity Flow Column Chromatography (CC)
The extract (12.95 g) was separated by CC on 1.2 kg silica (particle size 0.063 to 0.2 mm; Merck,
(Darmstadt, Germany), column dimensions 108 cm × 6 cm). The column was covered with aluminum
foil to prevent the light-induced polymerization of alkamides with a polyinic structure moiety [16].
The silica was equilibrated at 90:10 n-hexane/EtOAc (2.4 L). The flow was adjusted to 1 mL/min,
and 10 mL were collected per tube for the first 459 tubes. From tube 460 to tube 2023, 20 mL were
collected per tube. A gradient with an increasing amount of EtOAc was used: n-hexane/EtOAc 90:10
(3 L); 80:20 (1.7 L); 70:30 (6.8 L); 60:40 (1.7 L); 50:50 (1 L); 40:60 (3.7 L); 30:70 (1 L); and 20:80 (3.7 L).
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Finally, 3 L of isopropanol was used to obtain the most polar fraction. Related eluates were combined
after TLC control (silica gel 60 F254, Merck (10 cm × 20 cm); detection: anisaldehyde/sulfuric acid,
UV 254 nm, 366 nm and daylight; elution: current solvent mixture of the CC column). The fractionation
is summarized in Table 2.
Table 2. Column chromatography (CC) fractions of A. pyrethrum L. (CH2Cl2 extract).
Fractions and
Combined Eluates * Elution Volume (mL) ** Yield (g) Isolated Compounds
I-VIII 1–540 4455 0.71977
IX 541–550 200 0.0921
X 551–565 320 0.1638
XI 566–585 300 0.0801
XII 586–625 670 0.3187
XIII 626–660 530 0.4814
XIV 661–690 410 0.2181
XV 691–720 370 0.1548 2, 3, 4
XVI 721–819 1020 0.3595
XVII 820–890 980 0.2426
XVIII 891–909 330 0.0696
XIX 910–940 510 0.1803 1
XX 941–1010 760 0.3141 1, 5, 6
XXI 1011–1080 840 0.5080
XXII 1081–1140 850 0.5072 8, 9, 10
XXIII 1141–1200 710 0.1973
XXIV 1201–1210 83 0.0244
XXV 1211–1225 120 0.0381
XXVI 1226–1280 490 0.1175
XXVII 1281–1319 340 0.0619
XXVIII 1320–1335 230 0.0493
XXIX 1336–1380 780 0.1580
XXX 1381–1410 480 0.1136
XXXI 1411–1470 950 0.1796
XXXII 1471–1750 4420 0.5834
XXXIII 1751–1830 1230 0.0782
XXXIV 1831–1875 540 0.0508
XXXV 1876–1885 80 0.7643
XXXVI 1886–1919 520 0.3215
XXXVII 1920–1959 800 0.1256
XXXVIII 1960–2023 1080 0.1762
Total: Total:
25,398 7.4498
* tube 1–459: 10 mL; tube 460–2023: 20 mL; ** eluate amounts determined volumetrically.
3.2.4. Purification by Preparative High Performance Liquid Chromatography (HPLC/UV-DAD)
The preparative HPLC isolation of all alkamides was performed on a Jasco (Groß-Umstadt,
Germany) prep. HPLC system (pump: PU-2087 plus; diode array detector MD 2018 plus; column
thermostat CO 2060 plus; autosampler AS 2055 plus; LC Net II ADC Chromatography Data Solutions;
sample injection loop: 2000 µL) on a Reprosil 100 C-18 column (5 µm, 250 mm × 20 mm) column
(precolumn: C-18, 5 µm, 30 mm × 20 mm) with a binary gradient (A: water (Millipore); B: acetonitrile
(HPLC grade)) at 15 mL/min with: 0 to 5 min: linear from 40% B to 65% B; 5 to 30 min: isocratic
65% B; 30 min to 40 min: linear from 65% B to 100% B; 40 min to 50 min: isocratic 100% B.
The subfractions XIX and XV were each dissolved in a concentration of 10 mg/mL acetonitrile and
injected in portions of 400 µL. The subfractions XX and XXII were dissolved in a concentration of 10
mg/mL acetonitrile/water (70:30) each and injected in portions of 400 µL. Pellitorine (2), as well as
compounds 3 and 4 were isolated as white powders in yields of 0.6 mg (2), 0.8 mg (3), and 0.8 mg (4)
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from 108 mg of fraction XV. Anacycline (1) was purified in a yield of 3.5 mg from 36 mg of fraction XIX.
From a 120 mg of fraction XX, 9.2 mg of (5), 2.2 mg of (6) and 12.3 mg of anacycline (1) were obtained.
A yield of 7.8 mg of compound (7) could be purified from a 72 mg of fraction XXII. Furthermore,
compounds 8 and 9 were isolated as mixture (1:4) in a yield of 21.1 mg from a 72 mg of fraction XXII.
The compounds isolated from fraction XXII were obtained as yellowish-white powders.
3.2.5. Analytical Data
Tetradeca-2E,4E-dien-8,10-diynoic acid isobutylamide (anacycline, 1). UHPLC/+ESI-QqTOF MS:
Rt 7.42 min, MS (m/z): 272.2046 (calcd. for C18H26NO+: 272.2009); 1H-NMR (600 MHz, CDCl3;
δ (ppm), mult., J (Hz)): 7.18 (dd, 11,15; H-3); 6.19 (dd, 11, 15; H-4); 6.07 (dt, 7, 15; H-5); 5.79 (d, 15; H-2);
5.48 (br s; NH); 3.17 (t (2H), 6, 7; H-2′); 2.38 (m (4H); H-6, H-7); 2.23 (t (2H), 7; H-12); 1.80 (sept, 7; H-3′);
1.55 (tq, (2H), 7; H-13); 0.98 (t (3H), 7; H-14); 0.93 (d (6H), 7; H-4′, H-5′).
Deca-2E,4E-dienoic acid isobutylamide (pellitorine, 2). UHPLC/+ESI-QqTOF MS: Rt 7.26 min, MS (m/z):
224.2022 [M + H]+; calcd. for C14H26NO+: 224.2009; 1H-NMR (600 MHz, CDCl3; δ (ppm), mult., J (Hz)):
7.19 (dd, 10, 15; H-3); 6.13 (dd, 10, 15; H-4); 6.07 (dt, 7; 15; H-5); 5.74 (d, 15; H-2); 5.43 (br s; NH); 3.17
(dd (2H), 6; H-2′); 2.14 (dt, (2H), 7, 7; H-6); 1.80 (sept, 7; H-3′); 1.42 (tt, (2H), 7, 7; H-7); 1.28 (m (4H);
H-8, H-9 overlapping signals); 0.93 (d (6H), 7; H-4′, 5′); 0.89 (t (3H), 7; H-10).
Deca-2E,4E,9-trienoic acid isobutylamide (9,10-dehydropellitorine, 3). UHPLC/+ESI-QqTOF
MS: Rt 6.72 min, MS (m/z): 222.1855 [M + H]+; calcd. for C14H24NO+: 222.1855; 1H-NMR
(600 MHz, CDCl3; δ (ppm), mult., J (Hz)): 7.19 (dd, 10, 15; H-3); 6.14 (dd, 10, 15; H-4); 6.06 (dt, 15, 7;
H-5); 5.81 (dt, 7, 10; H-9); 5.75 (d, 15; H-2); 5.44 (br s; NH); 5.01 (ddt, 2, 2, 17; H-10 trans); 4.96 (ddt, 1, 2,
10; H-10 cis); 3.17 (t (2H), 6; H-2′); 2.17 (dt (2H), 7, 7; H-6); 2.06 (dt (2H) 7,7; H-8); 1.80 (sept, 7; H-3′);
1.52 (m (2H), 7; H-7) overlapping signals; 0.93 (d (6H), 7; H-4′, H-5′); 13C-NMR (150 MHz, CDCl3;
δ (ppm), mult.: 168.1, (s, C-1); 142.8 (d, H-5); 141.4 (d, C-3); 138.5 (d, C-9); 128.7 (d. C-4); 122.0 (d, C-2);
115.0 (t, C-10); 47.1 (t. C-2′); 33.3 (t, C-8); 32.4 (t, C-6); 28.8 (d, C-3′); 28.1 (t, C-7); 20.3 (q, C-4′ + C-5′);
All assignments confirmed by HSQC and HMBC experiments.
Deca-2E,4E-dienoic acid 2-phenylethylamide (4). UHPLC/+ESI-QqTOF MS: Rt 7.67 min, MS (m/z):
272.2026 [M + H]+; calcd. for C18H26NO+: 272.2009; 1H-NMR (600 MHz, CDCl3; δ (ppm), mult.,
J (Hz)): 7.31 (t (2H) 7; H-3′ ′, H-5′ ′); 7.23 (t, 7; H-4′ ′); 7.20 (d (2H) 7; H-2′ ′, H-6′ ′); 7.18 (dd, 10, 15; H-3);
6.11 (dd, 10, 15; H-4); 6.07 (dt, 7, 15; H-5); 5.67 (d, 15, H-2); 5.40 (br s; NH); 3.60 (dt (2H), 6, 7; H-2′);
2.85 (t (2H), 7; H-3′); 2.14 (dt (2H), 7, 7; H-6); 1.41 (tt (2H), 7, 7; H-7) overlapping signals; 1.28 (m (4H);
H-8, H-9) overlapping signals; 0.88 (t (3H), 7; H-10).
Undeca-2E,4E-dien-8,10-diynoic acid isopentylamide (5). UHPLC/+ESI-QqTOF MS: Rt 6.55 min, MS (m/z):
244.1732 [M + H]+; calcd. for C16H22NO+: 244.1696; 1H-NMR (400 MHz, CDCl3; δ (ppm), mult.,
J (Hz)): 7.17 (dd, 11, 15; H-3); 6.19 (dd, 11, 15; H-4); 6.04 (dt, 7, 15; H-5); 5.78 (d, 15, H-2); 5.48 (br s; NH);
3.35 (dt (2H), 6, 7; H-2′); 2.38 (m, (4H); H-6, H-7); 1.98 (s; H-11); 1.63 (sept, 7; H-4′); 1.42 (dt (2H), 8, 7;
H-3′); 0.92 (d (6H), 7, H-4′, H-5′).
Tetradeca-2E,4E,12Z-trien-8,10-diynoic acid isobutylamide (6). UHPLC/+ESI-QqTOF MS: Rt 7.23 min,
MS (m/z): 270.1881 [M + H]+; calcd. for C18H24NO+: 270.1852; 1H-NMR (400 MHz, CDCl3; δ (ppm),
mult., J (Hz)): 7.19 (dd, 11, 15; H-3); 6.21 (dd, 11, 15; H-4); 6.12 (dq, 7, 11; H-13); 6.08 (dt, 6, 15; H-5);
5.80 (d, 15, H-2); 5.50 (dt, 11, 1; H-12); (5.47 (br s, NH); 3.17 (dd (2H), 6, 7; H-2′); 2.46 (dt (2H), 6, 7; H-6);
2.41 (t, (2H) 7; H-7); 1.91 (dd (3H) 7, 2; H-14); 1.80 (sept, 7, H-3′); 0.93 (d (6H), 7, H-4′, H-5′).
Dodeca-2E,4E-dienoic acid 4-hydroxy-2-phenylethylamide (7). UHPLC/+ESI-QqTOF MS: Rt 7.66 min,
MS (m/z): 316.2273 [M + H]+; calcd. for C20H30NO2+: 316.2271; 1H-NMR (600 MHz, CDCl3;
δ (ppm), mult., J (Hz)): 7.18 (dd, 10, 15; H-3); 7.03 (d (2H) 8; H-2′ ′, H-6′ ′); 6.79 (d (2H) 8; H-3′ ′,
H-5′ ′); 6.10 (dd, 10, 15; H-4); 6.06 (dt, 7, 15; H-5); 5.68 (d, 15; H-2); 5.52 (br s; NH); 3.56 (dt (2H), 7, 7;
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H-2′); 2.76 (t, (2H) 7, H-3′); 2.13 (dt, 7, 7; H-6); 1.40 (tt, 7, 7; H-7); 1.27 (m (8H); H-8, H-9, H-10, H-11)
overlapping signals; 0.92 (d (6H), 7, H-4′, 5′); 0.88 (t (3H), 7, H-12).
Undeca-2E,4E-dien-8,10-diynoic acid 2-phenethylamide (8). UHPLC/+ESI-QqTOF MS: Rt 6.53 min,
MS (m/z): 278.1542 (calcd. for C19H20NO+: 278.1539); 1H-NMR (600 MHz, CDCl3; δ (ppm), mult.,
J (Hz)): 7.31 (t (2H) 7; H-3′ ′, H-5′ ′); 7.23 (t, 7; H-4′ ′); 7.20 (d (2H) 7; H-2′ ′, H-6′ ′); 7.18 (dd, 11, 15; H-3);
6.17 (dd, 11, 15; H-4); 6.06 (m [dt]; H-5); 5.56 (br s; NH); 3.61 (dt (2H), 6, 7; H-2′); 2.85 (t (2H), 7; H-3′);
2.38 (m (4H); H-6, 7); 1.98 (s; H-11).
Deca-2E,4E-dienoic acid 4-hydroxy-2-phenylethylamide (9) UHPLC/+ESI-QqTOF MS: Rt 6.66 min,
MS (m/z): 288.1973 [M + H]+; calcd. for C18H26NO2+: 288.1958; 1H-NMR (600 MHz, CDCl3;
δ (ppm), mult., J (Hz)): 7.19 (dd, 10, 15; H-3); 7.02 (d (2H) 8; H-2′ ′, H-6′ ′); 6,80 (d (2H) 8; H-3′ ′,
H-5′ ′); 6.10 (dd, 10, 15; H-4); 6.06 (m [dt]; H-5); 5.69 (d, 15, H-2); 5.56 (br s; NH); 3.55 (dt (2H), 6, 7; H-2′);
2.76 (t (2H), 7; H-3′); 2.13 (dt, (2H) 7, 7; H-6); 1.41 (tt (2H), 7; H-7); 1.29 (m (4H); H-8, H-9); 0.88 (t (3H),
7, H-10).
All analytical data were in full agreement with literature data: compounds 1, 5, 6 [11], 2, 8 [12],
4 [13], 7, 9 [15].
3.3. In Vitro Assays and IC50 Determination
Tests for antiprotozoal activities were carried out using established standard protocols at the
Swiss Tropical and Public Health Institute (Swiss TPH, Basel, Switzerland). The assays and the IC50
determinations were performed essentially as described previously [17]. The compounds used as
positive controls in the various bioassays (see Table 1) were of commercial origin, with the exception
of melarsoprol, which was a gift from the WHO. Their purity (generally >95%) was specified by the
manufacturers. The purity of test compounds was assessed by UHPLC/MS analyses and found to be
>90% in case of compounds 1–6 and >80% in case of 7. Compounds 8 + 9 represented a mixture in
a ratio of approximately 1:4 (Figure S10).
4. Conclusions
The present study adds to the knowledge on the alkamides in roots of A. pyrethrum, a medicinal
drug used since ancient times. Compounds 3, 4, and 5 are reported as constituents of A. pyrethrum for
the first time. Compound 3—deca-2E,4E,9-trienoic acid isobutylamide (9,10-dehydropellitorine)—is
a hitherto-undescribed natural product. In the case of compound 6, the configuration of the
12,13-double bond, which had previously been reported as E (although without support by any
data), could be unambiguously assigned as Z. The reported ethnomedicinal use of A. pyrethrum as an
antimalarial might be explained by the activity of its lipophilic constituents, as the dichloromethane
extract presented moderate in vitro activity against Plasmodium falciparum, which is in the same
range as that of the most active alkamides isolated, namely pellitorine (2) and dodeca-2E,4E-dienoic
acid 4-hydroxy-2-phenylethylamide (7), of which the latter also presented considerable toxicity
against mammalian cells. However, the overall antiparasitic activity is low and does not warrant
further exploitation.
Supplementary Materials: Supplementary materials are available online. The NMR and mass spectra of all
isolates are provided as supplementary Figures S1-SXY available online.
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